{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:56:19Z","timestamp":1787932579403,"version":"build-2784847793"},"reference-count":55,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Forensic Sciences"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>3,4\u2010Methylenedioxymethamphetamine (MDMA) or \u201cecstasy,\u201d is a commonly used drug worldwide, including in New Zealand, where 4.8% of the population aged 15\u2009years or over reported using it in a 2023\/2024 survey. This study provides additional insights on MDMA prevalence data in New Zealand by reporting toxicology data from Coronial and driving under the influence of drugs (DUID) cases positive for MDMA between 2010 and 2022. Presented alongside are data from MDMA drug seizures (tablets, powders\/crystals, and capsules) submitted by NZ Police or Customs during the same period. Of the 131 MDMA\u2010positive Coronial cases, 73 were quantified in peripheral postmortem blood (mean: 0.88\u2009mg\/L, range: 0.01\u20139.30\u2009mg\/L). Of the 193 DUID cases positive for MDMA, 186 were quantified in blood (mean: 0.23\u2009mg\/L, range: 0.01\u20137.30\u2009mg\/L). MDA was also quantified in peripheral blood in 33 Coronial cases (mean: 0.06\u2009mg\/L, range: 0.01\u20130.20\u2009mg\/L) and 79 DUID cases (mean: 0.03\u2009mg\/L, range: 0.01\u20130.21\u2009mg\/L). In both types of MDMA\u2010positive cases, 85% or more were positive for other drugs and\/or alcohol, with the most commonly co\u2010used substances being cannabis and alcohol. The demographics of MDMA users were comparable to those reported in previous studies. The prevalence of MDMA in drivers (1.8%) is similar to that reported in previous studies. There were 138 drug seizures with an average purity of 71% (range: 17\u2013101%), with capsules showing the highest overall purity. We envisage the data in this paper being used by forensic toxicologists, law enforcement and drug policy makers.<\/jats:p>","DOI":"10.1111\/1556-4029.70284","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:59:45Z","timestamp":1770897585000},"page":"1338-1350","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trends in toxicological findings and drug seizures of\n                    <scp>MDMA<\/scp>\n                    in New Zealand from 2010 to 2022"],"prefix":"10.1111","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0575-7734","authenticated-orcid":false,"given":"Thomas J.","family":"Sheehan","sequence":"first","affiliation":[{"name":"PHF Science  Porirua New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0640-0422","authenticated-orcid":false,"given":"Hilary J.","family":"Hamnett","sequence":"additional","affiliation":[{"name":"Department of Chemistry University of Lincoln  Lincoln UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah G. G.","family":"Russell","sequence":"additional","affiliation":[{"name":"PHF Science  Porirua New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Kappatos","sequence":"additional","affiliation":[{"name":"PHF Science  Porirua New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8877-3109","authenticated-orcid":false,"given":"Helen","family":"Poulsen","sequence":"additional","affiliation":[{"name":"PHF Science  Porirua New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"3","key":"e_1_2_10_2_1","first-page":"6","article-title":"History never repeats? New Zealand's history of drugs and the laws to control them","volume":"25","author":"Brown R","year":"2014","journal-title":"Matters of Substance"},{"key":"e_1_2_10_3_1","first-page":"1171","article-title":"Ecstasy use in New Zealand: findings from the 1998 and 2001 National Drug Surveys","volume":"116","author":"Wilkins C","year":"2003","journal-title":"N Z Med J"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2020.110367"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1039\/C9AY01403A"},{"key":"e_1_2_10_6_1","first-page":"11","article-title":"3,4\u2010methylenedioxymethamphetamine\u2013effects on human performance and behaviour","volume":"15","author":"Logan BK","year":"2003","journal-title":"Forensic Sci Rev"},{"key":"e_1_2_10_7_1","volume-title":"Report: drug use in Aotearoa 2022\/23","author":"New Zealand Drug Foundation","year":"2024"},{"key":"e_1_2_10_8_1","unstructured":"New Zealand Drug Foundation.Report: Drug use in Aotearoa 2023\/24. Available from:https:\/\/drugfoundation.org.nz\/assets\/PageBlocks\/Downloads\/Drug\u2010use\u2010in\u2010Aotearoa_2023_24.pdf. Accessed 7 Jul 2025"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954\u2010024\u201000979\u2010y"},{"key":"e_1_2_10_10_1","unstructured":"EMCDDA.Recent changes in Europe's MDMA\/ecstasy market: Results from an EMCDDA trendspotter study. Available from:https:\/\/op.europa.eu\/en\/publication\u2010detail\/\u2010\/publication\/5c32bb40\u201010f1\u201011e6\u2010ba9a\u201001aa75ed71a1\/language\u2010en. Accessed 7 Jul 2025"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2022.156956"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.09.007"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2020.1784914"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/00450618.2021.1921267"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2134"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2605"},{"key":"e_1_2_10_17_1","unstructured":"KuypersKPC RamaekersJG.The effects of \u00b13 4 methylenedioxymethamphetamine (MDMA) with and without alcohol on actual driving performance: preliminary results. In: Proceedings of the 17th International Conference on Alcohol Drugs and Traffic Safety; 2004 Aug 8\u201313; Glasgow UK: ICADTS;2004."},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1520\/JFS15166J"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/00450618.2019.1687753"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2020.110190"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aap.2023.107413"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arrct.2021.100175"},{"key":"e_1_2_10_23_1","unstructured":"Stats NZ.Census. Available from:https:\/\/www.stats.govt.nz\/topics\/census\/. Accessed 25 Sep 2025"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100460"},{"key":"e_1_2_10_25_1","volume-title":"Commission decision of 12 august 2002 implementing council directive 96\/23\/EC concerning the performance of analytical methods and the interpretation of results (text with EEA relevance) (notified under document number C(2002) 3044)","author":"EU","year":"2002"},{"issue":"3","key":"e_1_2_10_26_1","first-page":"11","article-title":"Statistics primer for the modern forensic toxicologist: chapter\u00a09 \u2013 Descriptive statistics: (almost) all you need to know in just a few numbers","volume":"54","author":"Desharnais B","year":"2024","journal-title":"TIAFT Bull"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkaa193"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1520\/JFS15211J"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2007.03.030"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/33.7.366"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.102630"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0379\u20100738(96)02095\u20106"},{"key":"e_1_2_10_33_1","first-page":"24","article-title":"MDMA poisoning deaths at a rave party in Sri Lanka","volume":"55","author":"Gunawardane SLR","year":"2025","journal-title":"TIAFT Bull"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkaa042"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/29.5.296"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkae024"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2021.101454"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.09.016"},{"key":"e_1_2_10_39_1","unstructured":"EMCDDA.EU drug markets report 2013: A strategic analysis. Available from:https:\/\/www.europol.europa.eu\/publications\u2010events\/publications\/eu\u2010drug\u2010markets\u2010report\u20102013\u2010strategic\u2010analysis. Accessed 7 Jul 2025"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2016.01.017"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/15389588.2020.1712715"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/ip\u20102024\u2010045342"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2022.111325"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2019.110004"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jflm.2012.10.005"},{"key":"e_1_2_10_46_1","unstructured":"EUDA.Statistical Bulletin 2025 \u2013 Prevalence of drug use. Available from:https:\/\/www.euda.europa.eu\/data\/stats2025\/gps_en. Accessed 25 Sep 2025"},{"key":"e_1_2_10_47_1","unstructured":"Office for National Statistics.Drug misuse in England and Wales: Year ending March 2024. Available from:https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/crimeandjustice\/articles\/drugmisuseinenglandandwales\/yearendingmarch2024. Accessed 25 Sep 2025"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsisyn.2020.06.003"},{"key":"e_1_2_10_49_1","first-page":"1341","volume-title":"Disposition of toxic drugs and chemicals in man","author":"Baselt RC","year":"2020"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1520\/JFS2003401"},{"key":"e_1_2_10_51_1","volume-title":"Proceedings of the 17th International Conference on Alcohol, Drugs and Traffic Safety; 2004 Aug 8\u201313; Glasgow, UK","author":"Lamers CTJ","year":"2004"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2008.69.202"},{"key":"e_1_2_10_53_1","unstructured":"UNODC.Word drug report 2025 \u2013 Special points of interest. Available from:https:\/\/www.unodc.org\/documents\/data\u2010and\u2010analysis\/WDR_2025\/WDR25_Special_points_of_interest.pdf. Accessed 25 Sep 2025"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2018.11.027"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107772"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2024.112226"}],"container-title":["Journal of Forensic Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1556-4029.70284","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1556-4029.70284","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1556-4029.70284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:46:10Z","timestamp":1777963570000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1556-4029.70284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1111\/1556-4029.70284"],"URL":"https:\/\/doi.org\/10.1111\/1556-4029.70284","archive":["Portico"],"relation":{},"ISSN":["0022-1198","1556-4029"],"issn-type":[{"value":"0022-1198","type":"print"},{"value":"1556-4029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"2025-07-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}